Marshall Wace
CRMD icon

Marshall Wace’s CorMedix CRMD Stock Holding History

Marshall Wace’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12M Buy
779,535
+276,570
+55% +$2.18M ﹤0.01% 1268
2026
Q1 		$3.42M Sell
502,965
-1,463,297
-74% -$10.8M ﹤0.01% 1504
2025
Q4 		$22.9M Sell
1,966,262
-1,507,232
-43% -$16.7M 0.02% 590
2025
Q3 		$40.4M Buy
3,473,494
+893,518
+35% +$10.8M 0.04% 389
2025
Q2 		$31.8M Buy
2,579,976
+2,349,451
+1,019% +$25.9M 0.04% 423
2025
Q1 		$1.42M Buy
+230,525
New +$2.39M ﹤0.01% 1623
2024
Q4 		– Sell
-161,755
Closed -$1.31M – 2637
2024
Q3 		$1.31M Buy
161,755
+9,480
+6% +$51.3K ﹤0.01% 1535
2024
Q2 		$659K Buy
152,275
+79,619
+110% +$404K ﹤0.01% 1860
2024
Q1 		$308K Sell
72,656
-390,350
-84% -$1.35M ﹤0.01% 2101
2023
Q4 		$1.74M Sell
463,006
-451,163
-49% -$1.55M ﹤0.01% 1278
2023
Q3 		$3.38M Sell
914,169
-524,709
-36% -$2.09M 0.01% 1012
2023
Q2 		$5.7M Buy
1,438,878
+1,237,479
+614% +$6.12M 0.01% 961
2023
Q1 		$834K Buy
201,399
+48,024
+31% +$196K ﹤0.01% 1899
2022
Q4 		$647K Buy
153,375
+110,298
+256% +$390K ﹤0.01% 2266
2022
Q3 		$122K Sell
43,077
-101,114
-70% -$421K ﹤0.01% 3165
2022
Q2 		$579K Buy
144,191
+110,536
+328% +$411K ﹤0.01% 2725
2022
Q1 		$184K Buy
+33,655
New +$154K ﹤0.01% 3122
2019
Q4 		– Sell
-4,552
Closed -$29K – 1753
2019
Q3 		$29K Buy
+4,552
New +$38.3K ﹤0.01% 1570

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace's CRMD Position: Q2 2026 in Review

Marshall Wace increased its CorMedix (CRMD) stake by 55% in Q2 2026, buying an estimated $2.18M and bringing the position to 779,535 shares worth $6.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Marshall Wace first reported a position in CRMD in Q3 2019 and has held it in 18 quarters since. The position peaked at $40.4M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Marshall Wace held 779,535 shares of CorMedix worth $6.12M as of Q2 2026.
  • Marshall Wace bought 276,570 CorMedix shares in Q2 2026, an estimated $2.18M.
  • CorMedix made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1268 holding.
  • Marshall Wace first reported a position in CorMedix in Q3 2019 and has held it in 18 quarters since.
  • Marshall Wace's CorMedix position peaked at $40.4M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.